Objectives To answer a national research priority by comparing the risk-benefit and costs associated with reverse total shoulder replacement (RTSR) and anatomical total shoulder replacement (TSR) in patients having elective primary shoulder replacement for osteoarthritis.
Design Population based cohort study using data from the National Joint Registry and Hospital Episode Statistics for England.
Setting Public hospitals and publicly funded procedures at private hospitals in England, 2012-20.
Participants Adults aged 60 years or older who underwent RTSR or TSR for osteoarthritis with intact rotator cuff tendons. Patients were identified from the National Joint Registry and linked to NHS Hospital Episode Statistics and civil registration mortality data. Propensity score matching and inverse probability of treatment weighting were used to balance the study groups.
Main outcome measures The main outcome measure was revision surgery. Secondary outcome measures included serious adverse e
Autism Research Spurs Key Shift in Suicide Prevention Policy
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Association between surgeon volume and patient outcomes after elective shoulder replacement surgery using data from the National Joint Registry and Hospital Episode Statistics for England: population based cohort study
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.
Treating post-infectious smell loss in COVID-19 patients
Thought LeadersProfessor Carl PhilpottAcademic SurgeonUniversity of East Anglia
News-Medical catches up with Professor Carl Philpott about the latest findings regarding COVID-19 and smell loss (anosmia), and how sufferers of smell loss post-infection can be treated.
We last interviewed you back in the early stages of the COVID pandemic about smell loss and COVID-19, when it was becoming increasingly recognized as an official symptom. How has your research and knowledge developed since then?
Firstly, after official recognition by the WHO and subsequently, the UK government, it was about showing just how common smell dysfunction was. Pooled evidence showed an incidence of about 60% of those being infected with COVID-19.